Care risks

Does “common” mean “minor”?

Not always. Most reported effects are stomach-related, but the label also covers uncommon problems that need fast attention and history that can rule the medicine out.

This page puts the warnings from the official FDA prescribing information into plain words. It cannot decide whether semaglutide is right for one person.

A bright white paper circle protected by layered black and slate paper arcs
The full picture joins health history, symptoms, and follow-up.
Myth

Stomach upset is all that matters.

Short answer

Stomach problems are the most common. The label also warns about the gallbladder, pancreas, and kidneys. Severe allergy is another risk. Some health histories rule the drug out.

The label in plain words

Numbers from a trial describe a group, not one person’s odds. The comparison group matters because some symptoms happened without the medicine too.

The common pattern

Across the Wegovy weight-management trials, nausea was reported by 44 in 100 people using the medicine and 16 in 100 using a dummy injection. Diarrhea was reported by 30 in 100 and 16 in 100, respectively.

The thyroid note

A boxed warning is the FDA’s strongest kind of warning. Every approved semaglutide label has one about tumors in thyroid C-cells, a type of cell in the thyroid. The tumors appeared in rats and mice; the labels say it is unknown whether semaglutide causes them in people.

The labels rule semaglutide out for anyone who has had medullary thyroid cancer, a rare type, or who has it in the family, and for people with MEN 2, a rare condition passed down in families. If you are not sure about either one, ask a relative or your regular doctor before an online visit.

Signs that need fast help

The Wegovy label describes persistent or severe stomach pain, sometimes spreading to the back, as a possible sign of pancreas inflammation.

A serious allergic reaction can set in within seconds or minutes. Call 911 for emergency signs: hard breathing, a face or tongue that swells, fainting, or severe hives.

A separate issue with compounded products

Compounded semaglutide is mixed to order by a pharmacy or a doctor. FDA has reports of wrong amounts being measured from it. Some people needed hospital care. The reports include errors by patients and health workers.

The FDA has also found fraudulent compounded products carrying a pharmacy's name on the label when that pharmacy did not exist or never made the product.

Finish with the stop-sign check
Annotated reading list

The records used here